1-2 of 2
Jordi Sierra Gil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART ® Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Andrew H. Wei, PhD FRACP, FRCPA, MBBS, Chun Yew Fong, MBBS,PhDFRACP,FRCPA, Pau Montesinos, MD PhD, Maria Calbacho, MD, Jordi Sierra Gil, MD PhD, Jaime Perez De Oteyza, MD PhD, Jacob M. Rowe, MB, BS, Ofir Wolach, MD, Yishai Ofran, MD, Yakir Moshe, MD, Jichao Sun, PhD, Jan Baughman, MPH, Eileen McNulty, MS, Ezio Bonvini, MD, Jon M. Wigginton, MD, Jan K Davidson-Moncada, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2662.
https://doi.org/10.1182/blood-2019-125966
Published: 2019
Journal Articles

Profile of Chronic Transfusion-Dependent Patients In Spain (20CH Study)

Raquel de Paz, Ma Carmen Losada Castillo, Matías Díaz Sánchez, Juan García-Talavera, Teresa Pascual García, Teresa Bernal Del Castillo, Rafael Franco Osorio, Pilar Giraldo, Carmen Pedro, Antoni Julià, Andreu Llorente, Ma Luz Martino Galiana, Marta Dueñas Usategui, Manuel Jurado Chacón, Iñigo Romón, Dolores Morales, Concha Zamora De Pedro, Jose Luis Díez, Isabel Sanjuán, Jordi Sierra Gil, Luis Palomera
Journal: Blood
Blood (2010) 116 (21): 4408.
https://doi.org/10.1182/blood.V116.21.4408.4408
Published: 2010